QQ客服 官方微博 反馈留言

	CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase
	Wang, Suna; Han, Qunying; Zhang, Guoyu; Zhang, Ni; Li, Zhu; Chen, Jinghong; Lv, Yi; Li, Na; Xing, Fanfan; Tian, Ningqiang
刊名	INTERNATIONAL IMMUNOPHARMACOLOGY
	2011
卷号	11期号:[db:dc_citation_issue]页码:406-411
关键词	Chronic hepatitis B HBcAg(18-27) CpG ODN IFN-gamma Cytotoxic T lymphocyte response HIV-Tat(49-57)
ISSN号	1567-5769
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4499229
专题	西安交通大学
推荐引用方式 GB/T 7714	Wang, Suna,Han, Qunying,Zhang, Guoyu,et al. CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2011,11([db:dc_citation_issue]):406-411.
APA	Wang, Suna.,Han, Qunying.,Zhang, Guoyu.,Zhang, Ni.,Li, Zhu.,...&Liu, Zhengwen.(2011).CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase.INTERNATIONAL IMMUNOPHARMACOLOGY,11([db:dc_citation_issue]),406-411.
MLA	Wang, Suna,et al."CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase".INTERNATIONAL IMMUNOPHARMACOLOGY 11.[db:dc_citation_issue](2011):406-411.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。